Daniel Friedman

Daniel Friedman has held various roles in different companies throughout their work experience. Daniel started their career as an Investment Banking Summer Analyst at Royal Bank of Scotland in 2014. Following that, they worked as a Health Care Investment Banking Analyst at Raymond James Financial, Inc. from 2015 to 2017. In 2018, they joined BroadOak Capital Partners as an Associate and later became a Vice President in 2022. Daniel has also served as a Board Observer at Avidien Technologies Incorporated from January to December 2022. Additionally, they have been a Board Member at PBS Biotech since September 2023 and a Board Observer at Biolog, Inc. since May 2022.

Daniel Friedman attended Scarborough High School, but no specific degree or field of study was mentioned. After high school, they went on to obtain a Bachelor of Business Administration (BBA) degree in Accounting and Finance from the University of Michigan - Stephen M. Ross School of Business. In addition to their formal education, they have also obtained certifications in Platform Management from DealCloud, Basic Security in the Field II from the United Nations, and Deputy for Early Heart Attack Care from the American College of Cardiology. Daniel also completed the Bloomberg Essentials Training Program in Fixed Income, Commodities, FX, and Equities, although the specific details regarding the certification were not provided.